Prostate News Archive
24-Oct-2011
PSA test valuable in predicting biopsy need, low-risk prostate cancer, study finds
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a new study has found. Prostate Cancer: Why Men Will Likely Ignore the Calls to Skip PSA Tests
In our war against cancer, men don't hear about the downsides of screening PSA test predicts biopsy need and prostate cancer development
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, Calif.
Back to Prostate News Archive
